Stocks in Play: BriaCell Therapeutics Corp.
Monday, April 28, 2025
10:51 AM EST - BriaCell Therapeutics Corp. : Is presenting positive data from its Phase 2 study of lead product candidate, Bria-IMT™, in metastatic breast cancer, and from its preclinical Bria-OTS+ platform at the 2025 American Association for Cancer Research (AACR) Annual Meeting taking place from April 25th – 30th at McCormick Place Convention Center, Chicago, IL. In addition, Phase 3 early biomarker data will be presented as a late breaking abstract. BriaCell Therapeutics Corp. (T.BCT ) shares were down $0.52 at 6.74.Stocks in Play: BriaCell Therapeutics Corp., Mon, 28 Apr 2025 10:57:07 EST
